USA v. King Pharmaceuticals Inc, et al
ROBERT N. YOUNG |
KING PHARMACEUTICALS INC, WYETH and PFIZER INC, As Successor in Interest to King Pharmaceuticals Inc and Wyeth |
23-2073 |
June 16, 2023 |
U.S. Court of Appeals, Third Circuit |
Other Statutes: False Claims Act |
Docket Report
This docket was last retrieved on August 3, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 18 Document by Appellant in Support of Appeal. Certificate of Service dated 08/04/2023. Service made by ECF. (PDB) [Entered: 08/04/2023 11:16 AM] |
Filing 17 Document by Appellant in Support of Appeal. Certificate of Service dated 08/02/2023. Service made by ECF. (PDB) [Entered: 08/02/2023 09:32 AM] |
Filing 16 Document by Appellant in Support of Appeal. Certificate of Service dated 08/02/2023. Service made by ECF. (PDB) [Entered: 08/02/2023 08:50 AM] |
Filing 15 Document by Appellant in Support of Appeal. Certificate of Service dated 07/27/2023. Service made by ECF. (PDB) [Entered: 07/27/2023 08:41 PM] |
Filing 14 Document by Appellant in Support of Appeal. Certificate of Service dated 07/21/2023. Service made by ECF. (PDB) [Entered: 07/21/2023 04:48 PM] |
Filing 13 Letter by Appellant to the Court in Support of Appeal. Certificate of Service dated 07/21/2023. Service made by ECF. (PDB) [Entered: 07/21/2023 04:47 PM] |
Filing 12 SUPPLEMENTAL RESPONSE on behalf of Appellant Robert N. Young to Appellee's July 11, 2023 Written Argument. Certificate of Service dated 07/20/2023. Service made by ECF. (PDB) [Entered: 07/20/2023 12:54 PM] |
Filing 11 ECF FILER: Response filed by Appellees King Pharmaceuticals Inc, Pfizer Inc and Wyeth to Legal Division letter. Certificate of Service dated 07/11/2023. [23-2073] (AJH) [Entered: 07/11/2023 04:05 PM] |
Filing 10 RESPONSE on behalf of Appellant Robert N. Young to Legal Division letter advising of possible dismissal. Certificate of Service dated 07/10/2023. Service made by ECF. (PDB) [Entered: 07/10/2023 04:46 PM] |
Filing 9 Notice received from the district court that the docketing and filing fees were paid by the appellant on 06/30/2023. (PDB) [Entered: 07/03/2023 11:32 AM] |
Filing 8 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Wyeth. [23-2073] (AJH) [Entered: 06/30/2023 01:17 PM] |
Filing 7 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Pfizer Inc. [23-2073] (AJH) [Entered: 06/30/2023 01:16 PM] |
Filing 6 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee King Pharmaceuticals Inc. [23-2073] (AJH) [Entered: 06/30/2023 01:14 PM] |
Filing 5 ECF FILER: ENTRY OF APPEARANCE from Andrew J. Hoffman II on behalf of Appellee(s) King Pharmaceuticals LLC f/k/a King Pharmaceuticals, Inc.; Wyeth LLC f/k/a Wyeth; Pfizer Inc.. [23-2073] (AJH) [Entered: 06/30/2023 01:10 PM] |
Filing 4 ECF FILER: ENTRY OF APPEARANCE from Lianna M. Bash on behalf of Appellee(s) King Pharmaceuticals LLC f/k/a King Pharmaceuticals, Inc.; Wyeth LLC f/k/a Wyeth; Pfizer Inc.. [23-2073] (LB) [Entered: 06/30/2023 01:06 PM] |
Filing 3 LEGAL DIVISION LETTER SENT advising that the case has been listed for possible dismissal due to jurisdictional defect. (MW) [Entered: 06/21/2023 02:42 PM] |
Filing 2 RECORD available on District Court CM/ECF. (PDB) [Entered: 06/16/2023 03:09 PM] |
Filing 1 CIVIL CASE DOCKETED. Notice filed by Appellant Robert N. Young in District Court No. 2-02-cv-02704. (PDB) [Entered: 06/16/2023 03:07 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.